Tricida Aktie - TCDA

Professionelle Tools für Privatanleger.

Premium

Current Price

0,108

Gebot

0,104

Fragen

0,105

Volumen

0,00 Tagesbereich 0,00

0,00 52-Wochen-Bereich 0,00

Handelsende

0,108

Handelsbeginn

Letzte Trade

Letzter Handelszeitpunkt

Durchschnittliches Volumen (3 Mio.)

Finanzvolumen

VWAP

Tricida Announces Third Quarter 2022 Financial Results

Tricida, Inc. (Nasdaq: TCDA) announced today financial results for the three and nine months ended September 30, 2022 and provided an update on...

Tricida Provides Strategic Update

Tricida, Inc. (NASDAQ: TCDA), announced today that the Board of Directors has authorized Tricida to initiate a review of strategic alternatives...

Tricida Reports Topline Results from the VALOR-CKD Phase 3 Trial of Veverimer

Webcast today at 8:00 am Eastern Time Tricida, Inc. (NASDAQ: TCDA) announced today the top-line results from its VALOR-CKD renal outcomes...

Tricida Announces $125 Million Debt Facility with Hercules Capital

Tricida, Inc. (Nasdaq: TCDA) announced today that it has entered into a debt facility with Hercules Capital, Inc. (NYSE: HTGC), a leader in...

Tricida Announces the Selection of the VALOR-CKD Trial for an Oral Presentation in the High-Impact Clinical Trials Session at ASN Kidney Week 2022

Tricida, Inc. (Nasdaq: TCDA) announced today that a late-breaking clinical trial abstract on the Phase 3, VALOR-CKD renal outcomes trial has been...

Zeitraum †	Änderung	Änderung %	Handelsbeginn	Hoch	Niedrig	Durchsch. Volumen	VWAP
1	0	0	0	0	0	0	0	CS
4	0	0	0	0	0	0	0	CS
12	0	0	0	0	0	0	0	CS
26	0	0	0	0	0	0	0	CS
52	0	0	0	0	0	0	0	CS
156	0	0	0	0	0	0	0	CS
260	0	0	0	0	0	0	0	CS

TCDA - Frequently Asked Questions (FAQ)

What is the current Tricida share price?

The current share price of Tricida is US$ 0,108

What is the 1 year trading range for Tricida share price?

Tricida has traded in the range of US$ 0,00 to US$ 0,00 during the past year

Volumen
% Tops
% Flops

Symbol	Preis	Vol.
GTIGraphjet Technology	US$ 0,2411 (74,71%)	775,25k
ARBBARB IOT Group Ltd	US$ 0,8838 (69,96%)	5,84M
GITSGlobal Interactive Technologies Inc	US$ 3,61 (60,12%)	71
AGHAureus Greenway Holdings Inc	US$ 1,03 (33,77%)	4,82M
NVNINVNI Group Ltd	US$ 0,3379 (28,72%)	22,94M
SYRESpyre Therapeutics Inc	US$ 13,13 (-27,94%)	1
RETOReTo Eco Solutions Inc	US$ 0,659 (-25,54%)	56,29k
OMCLOmnicell Inc	US$ 28,00 (-25,11%)	392
OMEROmeros Corporation	US$ 6,01 (-24,69%)	8
ARHSArhaus Inc	US$ 7,01 (-24,30%)	5
NVNINVNI Group Ltd	US$ 0,3379 (28,72%)	22,94M
ARBBARB IOT Group Ltd	US$ 0,8838 (69,96%)	5,84M
BTOGBit Origin Ltd	US$ 0,4404 (23,02%)	5,61M
AGHAureus Greenway Holdings Inc	US$ 1,03 (33,77%)	4,82M
SHViShares Short Treasury Bond ETF	US$ 110,135 (0,01%)	4,13M

Foren

Foren anzeigen

Keine Diskussionen Gefunden.

Neuen Thread Erstellen

Marktdaten

News

Werkzeuge

Märkte

Entdecken

Hot Features

Follow Feed

Optionen-Flow

Watchlist

Tricida Inc (TCDA)

Professionelle Tools für Privatanleger.

Wichtige Statistiken und Details

TCDA Neueste Nachrichten

Tricida Announces Third Quarter 2022 Financial Results

Tricida Provides Strategic Update

Tricida Reports Topline Results from the VALOR-CKD Phase 3 Trial of Veverimer

Tricida Announces $125 Million Debt Facility with Hercules Capital

Tricida Announces the Selection of the VALOR-CKD Trial for an Oral Presentation in the High-Impact Clinical Trials Session at ASN Kidney Week 2022

Tricida to Present at the H.C. Wainwright 24th Annual Global Investment Conference

Tricida Announces Second Quarter 2022 Financial Results

Tricida to Report Second Quarter Financial Results and Host Conference Call and Webcast on Monday, August 8, 2022

Tricida Announces Administrative Stop of the VALOR-CKD Trial

Tricida Announces First Quarter 2022 Financial Results

TCDA - Frequently Asked Questions (FAQ)

Beweger

Foren

Kürzlich von Ihnen besucht

Unternehmen

Geschäft

Popular

App herunterladen

Zeitraum †	Änderung	Änderung %	Handelsbeginn	Hoch	Niedrig	Durchsch. Volumen	VWAP
1	0	0	0	0	0	0	0	CS
4	0	0	0	0	0	0	0	CS
12	0	0	0	0	0	0	0	CS
26	0	0	0	0	0	0	0	CS
52	0	0	0	0	0	0	0	CS
156	0	0	0	0	0	0	0	CS
260	0	0	0	0	0	0	0	CS

Zeitraum †	Änderung	Änderung %	Handelsbeginn	Hoch	Niedrig	Durchsch. Volumen	VWAP
1	0	0	0	0	0	0	0	CS
4	0	0	0	0	0	0	0	CS
12	0	0	0	0	0	0	0	CS
26	0	0	0	0	0	0	0	CS
52	0	0	0	0	0	0	0	CS
156	0	0	0	0	0	0	0	CS
260	0	0	0	0	0	0	0	CS

Trends

Toplisten

Marktdaten

News

Werkzeuge

Märkte

Entdecken

Hot Features

Follow Feed

Optionen-Flow

Watchlist

Tricida Inc (TCDA) Börsenkurse

Tricida Inc (TCDA)

Professionelle Tools für Privatanleger.

Wichtige Statistiken und Details

TCDA Neueste Nachrichten

Tricida Announces Third Quarter 2022 Financial Results

Tricida Provides Strategic Update

Tricida Reports Topline Results from the VALOR-CKD Phase 3 Trial of Veverimer

Tricida Announces $125 Million Debt Facility with Hercules Capital

Tricida Announces the Selection of the VALOR-CKD Trial for an Oral Presentation in the High-Impact Clinical Trials Session at ASN Kidney Week 2022

Tricida to Present at the H.C. Wainwright 24th Annual Global Investment Conference

Tricida Announces Second Quarter 2022 Financial Results

Tricida to Report Second Quarter Financial Results and Host Conference Call and Webcast on Monday, August 8, 2022

Tricida Announces Administrative Stop of the VALOR-CKD Trial

Tricida Announces First Quarter 2022 Financial Results

TCDA - Frequently Asked Questions (FAQ)

Beweger

Foren

Kürzlich von Ihnen besucht

Unternehmen

Geschäft

Popular

App herunterladen

Werbung entfernen

Zeitraum †	Änderung	Änderung %	Handelsbeginn	Hoch	Niedrig	Durchsch. Volumen	VWAP
1	0	0	0	0	0	0	0	CS
4	0	0	0	0	0	0	0	CS
12	0	0	0	0	0	0	0	CS
26	0	0	0	0	0	0	0	CS
52	0	0	0	0	0	0	0	CS
156	0	0	0	0	0	0	0	CS
260	0	0	0	0	0	0	0	CS